Skip to content

Research on the Improvement of Gait Function in Stroke Patients by Repetitive Transcranial Magnetic Stimulation

Research on the Improvement of Gait Function in Stroke Patients by Repetitive Transcranial Magnetic Stimulation

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103246
Enrollment
Unknown
Registered
2025-05-27
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Sponsors

Jinhua Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for stroke in the Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018 or the Chinese Guidelines for the Diagnosis and Treatment of Intracerebral Hemorrhage (2019); 2. First onset of the disease with a unilateral lesion; 3. Aged between 45 and 75 years old; 4.Stroke patients in the convalescent stage with a disease course of 2 to 12 weeks; 5.Stable vital signs and able to cooperate with the treatment.

Exclusion criteria

Exclusion criteria: 1.Have contraindications to Transcranial Magnetic Stimulation (TMS): intracranial metal implants, cochlear implants, cardiac pacemakers, cranial bone defects; 2.Suffering from progressive neurodegenerative diseases; 3.Patients with a history of epilepsy; 4.Patients with medical diseases in an unstable stage; 5. Patients with mental diseases such as severe depression and mania.

Design outcomes

Primary

MeasureTime frame
Lower Extremity Motor Function;10 - meter maximum walking speed;Balance;Walking Function Classification;Balance instrument indicators;

Countries

China

Contacts

Public ContactXiaohao Tong

Jinhua Central Hospital

1042594430@qq.com+86 130 0366 6881

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026